Episode

Episode 498: APCCC 2026 - mCRPC

Podcast: The Uromigos
Published: May 2, 2026
Duration seconds: 1290
Processing state: not_requested
Canonical source: https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-498-APCCC-2026---mCRPC-e3iojnl
Audio: https://anchor.fm/s/13347ea8/podcast/play/119344309/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-1%2F423277678-44100-2-98eb23f05af38.m4a
JSON: /v1/public/podcasts/the-uromigos-1214845/episodes/episode-498-apccc-2026-mcrpc
Markdown: /podcast/the-uromigos-1214845/episode-498-apccc-2026-mcrpc.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-498-apccc-2026-mcrpc/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-uromigos-1214845/episode-498-apccc-2026-mcrpc.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

This APCCC podcast with Elena Castro features a detailed discussion on recent advances and ongoing debates in the treatment of castrate resistant prostate cancer (CRPC), including the placement of lutetium, biomarker-driven therapy, and emerging treatment options.